Thought of the Week: What We Give
July 17, 2025
Thought of the Week: Do
t090111-Do-W2560.jpeg
Related:
Thought of the Week: Dissolving the Pain
July 9, 2025
Thought of the Week: What I Can Do
July 1, 2025
Thought of the Week – Kindness Grows Abundant
June 17, 2025
As I Grow Older
June 11, 2025
Honoring Dad on Father’s Day
June 10, 2025
Email me when people comment
Login
0 Comments
Edited by:
P. Berger
Caring for dementias such as Alzheimer's among family and friends, Peter committed to help preserve the dignity of people affected by Alzheimer's. AlzheimersWeekly.com is the fruit of that commitment.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Insulin
More Evidence Alzheimer’s is a Type of Diabetes
MEMORY PROBLEMS, an early sign of Alzheimer’s, are linked to glucose sugar deprivation in brain cells. So is diabetes, a well-known Alzheimer’s risk factor. How strongly connected is the Alzheimer’s-Sugar-Diabetes triangle?
No Comments
Drugs
How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs
The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?
3 Comments
Lewy Body
SPARK: What Happened to Robin Williams’ Brain?
TRAILER: Robin Williams and his battle with Lewy Body Dementia.
2 Comments
Drugs
Kisunla for Alzheimer’s Now 40% Safer
FDA approves a newly recommended dosing schedule for Kisunla (Donanemab). It’s significantly safer due to lowered ARIA-E rates, which has been the main problem with these drugs.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On